← Back to all trials
Active Not Recruiting
NCT02284308
Elderly With Locally Advanced Lung Cancer: Deciding Through Geriatric Assessment on the Optimal Treatment Strategy
Conditions: NSCLC
Sex: All
Ages: 75 Years – N/A
Healthy volunteers: No
Enrollment: 180
Sponsor: Maastricht Radiation Oncology
Location: Ziekenhuisgroep Twente Almelo
Summary
There is no detailed information available on benefits and harms of intensified treatment with concurrent RCHT among a subpopulation of elderly patients. Reliable tools are needed to distinguish the subgroup of fit patients from frail patients.
Eligibility Criteria
Inclusion criteria (according to the protocol):
* Any subtype of pathologically proven NSCLC, primary UICC Stage III disease;
* Age ≥ 75 years;
* No surgery or adjuvant chemotherapy for NSCLC in the last year;
* No prior radiotherapy to the ipsilateral thorax or mediastinum;
* No clinical superior vena cava syndrome;
* No diagnosis of other cancer within the last 3-years (except in situ carcinoma's and / or non-melanoma skin cancer);
* Written informed consent
Source: ClinicalTrials.gov (NCT02284308). StuddyBuddy aggregates publicly available trial information.
